Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Abstract 3909: Potential antitumor effect of a pan-PI3K inhibitor ZSTK474 on human sarcoma cell lines

Shingo Dan, Naomi Tamaki, Nachi Namatame, Yuya Yoshizawa, Mutsumi Okamura, Yumiko Nishimura, Kanami Yamazaki, Shin-ichi Yaguchi

Cancer Res (2019) 79 (13_Supplement): 3909.

https://doi.org/10.1158/1538-7445.AM2019-3909

Published: 01 July 2019

View articletitled, Abstract 3909: Potential antitumor effect of a pan-PI3K inhibitor ZSTK474 on human sarcoma cell lines

Journal Articles

Abstract 384: Identification of a lung adenocarcinoma cell line addicted to ERBB4, an actionable target for cancer therapy

Noritaka Tanaka, Kanami Yamazaki, Yuko Uno, Yoshimi Ohashi, Yumiko Nishimura, Masaaki Sawa, Shingo Dan

Cancer Res (2019) 79 (13_Supplement): 384.

https://doi.org/10.1158/1538-7445.AM2019-384

Published: 01 July 2019

View articletitled, Abstract 384: Identification of a lung adenocarcinoma cell line addicted to ERBB4, an actionable target for cancer therapy

Journal Articles

Abstract LB-357: Identification of a new inhibitor of the Golgi system, targeting ADP-ribosylation Factor 1 (Arf1) with potential for cancer therapy

Yoshimi Ohashi, Hiroshi Iijima, Noriyuki Yamaotsu, Kanami Yamazaki, Shigeo Sato, Mutsumi Okamura, Kenji Sugimoto, Shingo Dan, Shuichi Hirono, Takao Yamori

Cancer Res (2012) 72 (8_Supplement): LB-357.

https://doi.org/10.1158/1538-7445.AM2012-LB-357

Published: 15 April 2012

View articletitled, Abstract LB-357: Identification of a new inhibitor of the Golgi system, targeting ADP-ribosylation Factor 1 (Arf1) with potential for cancer therapy

Journal Articles

Abstract 4399: In vitro and in vivo evaluations of correlation between the activation status of signaling pathways and the efficacy of anticancer compounds in a panel of JFCR39 human cancer cell lines

Shingo Dan, Mutsumi Okamura, Mariko Seki, Kanami Yamazaki, Yumiko Mukai, Takao Yamori

Cancer Res (2011) 71 (8_Supplement): 4399.

https://doi.org/10.1158/1538-7445.AM2011-4399

Published: 15 April 2011

View articletitled, Abstract 4399: In vitro and in vivo evaluations of correlation between the activation status of signaling pathways and the efficacy of anticancer compounds in a panel of JFCR39 human cancer cell lines

Journal Articles

Correlating Phosphatidylinositol 3-Kinase Inhibitor Efficacy with Signaling Pathway Status: In silico and Biological Evaluations

Shingo Dan, Mutsumi Okamura, Mariko Seki, Kanami Yamazaki, Hironobu Sugita, Michiyo Okui, Yumiko Mukai, Hiroyuki Nishimura, Reimi Asaka, Kimie Nomura, Yuichi Ishikawa, Takao Yamori

Cancer Res (2010) 70 (12): 4982–4994.

https://doi.org/10.1158/0008-5472.CAN-09-4172

Published: 14 June 2010

View articletitled, Correlating Phosphatidylinositol 3-Kinase Inhibitor Efficacy with Signaling Pathway Status: In silico and Biological Evaluations

Includes: Supplementary data

Journal Articles

Abstract 2493: Inhibition of phosphoinositide 3-kinase suppressed growth of cancer cells with PIK3CA mutations or loss of PTEN expression via G₀/G₁ arrest of cell cycle but not apoptosis

Shingo Dan, Mutsumi Okamura, Hisashi Yoshimi, Yumiko Mukai, Kanami Yamazaki, Yasumichi Inoue, Aki Hanyu, Takeshi Imamura, Asako Sakaue-Sawano, Atsushi Miyawaki, Takao Yamori

Cancer Res (2010) 70 (8_Supplement): 2493.

https://doi.org/10.1158/1538-7445.AM10-2493

Published: 15 April 2010

View articletitled, Abstract 2493: Inhibition of phosphoinositide 3-kinase suppressed growth of cancer cells with PIK3CA mutations or loss of PTEN expression via G0/G1 arrest of cell cycle but not apoptosis

Journal Articles

Abstract #LB-214: Efficacy of PI3K inhibitors to PI3K mutants in enzyme and cell levels

Shingo Dan, Hironobu Sugita, Kanami Yamazaki, Takao Yamori

Cancer Res (2009) 69 (9_Supplement): LB-214.

Published: 01 May 2009

View articletitled, Abstract #LB-214: Efficacy of PI3K inhibitors to PI3K mutants in enzyme and cell levels

Journal Articles

A novel phosphatidylinositol 3-kinase inhibitor, ZSTK474 exerted antitumor activity against human tumor xenografts by oral administration

Shin-Ichi Yaguchi, Yasuhisa Fukui, Ichiro Koshimizu, Hisashi Yoshimi, Toshiyuki Matsuno, Hiroaki Goda, Shuichi Hirono, Kanami Yamazaki, Takao Yamori

Cancer Res (2005) 65 (9_Supplement): 399.

Published: 01 May 2005

View articletitled, A novel phosphatidylinositol 3-kinase inhibitor, ZSTK474 exerted antitumor activity against human tumor xenografts by oral administration

Journal Articles

Overexpression of cyclin B1 is associated with the enhancement of paclitaxcel-sensitivity in human gastric cancer cell lines

Yoko Yoshida, Kanami Yamazaki, Noriyuki Nakatsu, Shingo Dan, Shigeo Sato, Takashi Tsuruo, Takao Yamori

Cancer Res (2005) 65 (9_Supplement): 551.

Published: 01 May 2005

View articletitled, Overexpression of cyclin B1 is associated with the enhancement of paclitaxcel-sensitivity in human gastric cancer cell lines

Journal Articles

An Integrated Database of Chemosensitivity to 55 Anticancer Drugs and Gene Expression Profiles of 39 Human Cancer Cell Lines

Shingo Dan, Tatsuhiko Tsunoda, Osamu Kitahara, Rempei Yanagawa, Hitoshi Zembutsu, Toyomasa Katagiri, Kanami Yamazaki, Yusuke Nakamura, Takao Yamori

Cancer Res (2002) 62 (4): 1139–1147.

Published: 01 February 2002

View articletitled, An Integrated Database of Chemosensitivity to 55 Anticancer Drugs and Gene Expression Profiles of 39 Human Cancer Cell Lines

Journal Articles

Potent Antitumor Activity of MS-247, a Novel DNA Minor Groove Binder, Evaluated by an in Vitro and in Vivo Human Cancer Cell Line Panel

Takao Yamori, Akio Matsunaga, Shigeo Sato, Kanami Yamazaki, Akiko Komi, Kazuhiro Ishizu, Izumi Mita, Hajime Edatsugi, Yasuhiro Matsuba, Kimiko Takezawa, Osamu Nakanishi, Hiroshi Kohno, Yuki Nakajima, Hironori Komatsu, Toshio Andoh, Takashi Tsuruo

Cancer Res (1999) 59 (16): 4042–4049.

Published: 15 August 1999

View articletitled, Potent Antitumor Activity of MS-247, a Novel DNA Minor Groove Binder, Evaluated by an in Vitro and in Vivo Human Cancer Cell Line Panel

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 3909: Potential antitumor effect of a pan-PI3K inhibitor ZSTK474 on human sarcoma cell lines

Abstract 384: Identification of a lung adenocarcinoma cell line addicted to ERBB4, an actionable target for cancer therapy

Abstract LB-357: Identification of a new inhibitor of the Golgi system, targeting ADP-ribosylation Factor 1 (Arf1) with potential for cancer therapy

Abstract 4399: In vitro and in vivo evaluations of correlation between the activation status of signaling pathways and the efficacy of anticancer compounds in a panel of JFCR39 human cancer cell lines

Correlating Phosphatidylinositol 3-Kinase Inhibitor Efficacy with Signaling Pathway Status: In silico and Biological Evaluations

Abstract 2493: Inhibition of phosphoinositide 3-kinase suppressed growth of cancer cells with PIK3CA mutations or loss of PTEN expression via G₀/G₁ arrest of cell cycle but not apoptosis

Abstract #LB-214: Efficacy of PI3K inhibitors to PI3K mutants in enzyme and cell levels

A novel phosphatidylinositol 3-kinase inhibitor, ZSTK474 exerted antitumor activity against human tumor xenografts by oral administration

Overexpression of cyclin B1 is associated with the enhancement of paclitaxcel-sensitivity in human gastric cancer cell lines

An Integrated Database of Chemosensitivity to 55 Anticancer Drugs and Gene Expression Profiles of 39 Human Cancer Cell Lines

Potent Antitumor Activity of MS-247, a Novel DNA Minor Groove Binder, Evaluated by an in Vitro and in Vivo Human Cancer Cell Line Panel

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only